Skip to content

Clinical trials

Ovarian Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Country / region: Portugal Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20093
20103
20131
20142
20182
20202
20212
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting9
Active, not recruiting3
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
European Organisation for Research and Treatment of Cancer - EORTC4
Amgen2
Daiichi Sankyo2
Hoffmann-La Roche2
AbbVie1
Astellas Pharma Global Development, Inc.1
Boehringer Ingelheim1
Instituto Portugues Oncologia de Lisboa Francisco Gentil1
Medical Research Council1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms33
Fallopian Tube Neoplasms9
Breast Neoplasms5
Carcinoma, Ovarian Epithelial5
Endometrial Neoplasms5
Neoplasms5
Squamous Cell Carcinoma of Head and Neck4
Uterine Cervical Neoplasms4
Colorectal Neoplasms3
Melanoma3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.